Sanofi Net Current Asset Value from 2010 to 2024

SNY Stock  USD 50.03  0.80  1.63%   
Sanofi ADR Net Current Asset Value yearly trend continues to be fairly stable with very little volatility. Net Current Asset Value will likely drop to 0.00 in 2024. At this time, Sanofi ADR's Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to rise to about 1.1 B in 2024, whereas Total Revenue is likely to drop slightly above 31 B in 2024. . View All Fundamentals
 
Net Current Asset Value  
First Reported
2010-12-31
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
0.0
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Sanofi ADR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sanofi main balance sheet or income statement drivers, such as Depreciation And Amortization of 4 B, Interest Expense of 1.1 B or Selling General Administrative of 11.2 B, as well as many exotic indicators such as Price To Sales Ratio of 3.95, Dividend Yield of 0.0228 or PTB Ratio of 1.44. Sanofi financial statements analysis is a perfect complement when working with Sanofi ADR Valuation or Volatility modules.
  
This module can also supplement Sanofi ADR's financial leverage analysis and stock options assessment as well as various Sanofi ADR Technical models . Check out the analysis of Sanofi ADR Correlation against competitors.
For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.

Currently Active Assets on Macroaxis

When determining whether Sanofi ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sanofi ADR's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sanofi Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sanofi Adr Stock:
Check out the analysis of Sanofi ADR Correlation against competitors.
For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Sanofi Stock analysis

When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Is Sanofi ADR's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanofi ADR. If investors know Sanofi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanofi ADR listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.43)
Earnings Share
1.93
Revenue Per Share
18.492
Quarterly Revenue Growth
0.023
Return On Assets
0.0454
The market value of Sanofi ADR is measured differently than its book value, which is the value of Sanofi that is recorded on the company's balance sheet. Investors also form their own opinion of Sanofi ADR's value that differs from its market value or its book value, called intrinsic value, which is Sanofi ADR's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanofi ADR's market value can be influenced by many factors that don't directly affect Sanofi ADR's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanofi ADR's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanofi ADR is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanofi ADR's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.